CN115232773B - Bacillus licheniformis and application thereof in degradation of bletilla striata polysaccharide - Google Patents
Bacillus licheniformis and application thereof in degradation of bletilla striata polysaccharide Download PDFInfo
- Publication number
- CN115232773B CN115232773B CN202210938151.6A CN202210938151A CN115232773B CN 115232773 B CN115232773 B CN 115232773B CN 202210938151 A CN202210938151 A CN 202210938151A CN 115232773 B CN115232773 B CN 115232773B
- Authority
- CN
- China
- Prior art keywords
- bacillus licheniformis
- polysaccharide
- bletilla
- microbial inoculum
- microbial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000194108 Bacillus licheniformis Species 0.000 title claims abstract description 65
- 150000004676 glycans Chemical class 0.000 title claims abstract description 59
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 59
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 59
- 241001313857 Bletilla striata Species 0.000 title claims abstract description 17
- 230000015556 catabolic process Effects 0.000 title abstract description 18
- 238000006731 degradation reaction Methods 0.000 title abstract description 18
- 150000002482 oligosaccharides Polymers 0.000 claims abstract description 22
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 21
- 230000000593 degrading effect Effects 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 238000004321 preservation Methods 0.000 claims abstract description 10
- 239000002068 microbial inoculum Substances 0.000 claims description 41
- 230000000813 microbial effect Effects 0.000 claims description 18
- 238000000855 fermentation Methods 0.000 claims description 14
- 230000004151 fermentation Effects 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000002054 inoculum Substances 0.000 claims description 2
- 241001313855 Bletilla Species 0.000 abstract description 34
- 238000000034 method Methods 0.000 abstract description 17
- 229920000057 Mannan Polymers 0.000 abstract description 9
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 9
- 238000000053 physical method Methods 0.000 abstract description 5
- 230000001580 bacterial effect Effects 0.000 description 11
- 229920002752 Konjac Polymers 0.000 description 6
- 239000000252 konjac Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 229920002581 Glucomannan Polymers 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 229940046240 glucomannan Drugs 0.000 description 4
- 235000019823 konjac gum Nutrition 0.000 description 4
- 150000002772 monosaccharides Chemical group 0.000 description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000002550 fecal effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 244000247812 Amorphophallus rivieri Species 0.000 description 2
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 240000001080 Grifola frondosa Species 0.000 description 2
- 235000007710 Grifola frondosa Nutrition 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical compound OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 235000010485 konjac Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- -1 oligosaccharide monosaccharide Chemical class 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000004192 high performance gel permeation chromatography Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/02—Separating microorganisms from their culture media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/10—Bacillus licheniformis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The application discloses bacillus licheniformis and application thereof in degradation of bletilla striata polysaccharide. The Bacillus licheniformis strain is named Bacillus licheniformis BJ2022, the preservation unit is China center for type culture Collection, and the preservation number is CCTCC NO: M2022816. When the bacillus licheniformis is used for degrading mannans, isomannans and mannooligosaccharides, beta-1, 4-D-mannoside bonds can be broken, oligosaccharide fragments can be generated, and bletilla polysaccharide can be effectively degraded into bletilla oligosaccharide. Compared with the physical method and the chemical method, the bacillus licheniformis provided by the application is used for degrading the bletilla polysaccharide and the various mannans, isomannans and mannooligosaccharides containing beta-1, 4-D-mannoside bonds, has high efficiency, is green and environment-friendly, and is suitable for large-scale preparation of the bletilla oligosaccharide and other oligosaccharides.
Description
Technical Field
The application relates to the technical field of degradation of bletilla polysaccharide, in particular to bacillus licheniformis and application thereof in degradation of bletilla polysaccharide.
Background
The bletilla striata is a traditional rare and precious traditional Chinese medicinal material in China, and has extremely high ornamental value, medicinal value and economic value. The composition of the compounds in the bletilla tuber is more than 150, wherein the bletilla polysaccharide is the most abundant substance in the dry tuber, and the content can reach 60 percent at most. Bletilla polysaccharide is a high molecular viscosity polysaccharide, the chemical components of the polysaccharide are glucomannan (including beta-glucose and beta-mannose), monosaccharide residues are connected by beta-1, 4-glycosidic bonds, and the molar ratio of the two is about 1:4, the molecular weight is 70000-600000 Da. The bletilla striata polysaccharide has the biological activities of resisting bacteria, promoting wound healing, resisting tumor, resisting fibrosis, resisting oxidation, resisting digestive tract ulcer and the like, and has wide application in the industries of food, cosmetics and the like due to no stimulation and no side effect. The bletilla striata polysaccharide has high viscosity and poor water solubility, and brings great inconvenience in subsequent processing and utilization. In view of the absolute ratio of polysaccharide in bletilla tuber, how to effectively reduce the viscosity of polysaccharide while maintaining the bioactivity of polysaccharide has become a major scientific problem and industrial bottleneck currently faced by bletilla industry.
Bletilla oligosaccharides (typically less than 30) with a smaller degree of polymerization have increased water solubility and decreased viscosity compared to bletilla polysaccharides, and are more biologically active when administered orally into the intestinal tract. At present, the method for degrading bletilla polysaccharide into oligosaccharide mainly comprises three major types of chemical (such as acid and alkali hydrolysis), physical (such as ultrasonic) and biological methods, but the chemical method has the defects of severe reaction conditions, difficult quality control, large environmental pollution and low degradation efficiency in the physical method, and the biological method can effectively avoid the problems.
The microbial degradation method is an emerging polysaccharide degradation technology developed in recent years, adopts special microorganisms to efficiently degrade polysaccharide into oligosaccharide, is environment-friendly compared with the traditional chemical and physical methods, and is particularly suitable for large-scale preparation of the oligosaccharide.
Therefore, finding a microorganism capable of efficiently degrading bletilla striata polysaccharide becomes one of the key methods for solving the technical problems.
Disclosure of Invention
In view of the above, the embodiment of the application discloses bacillus licheniformis and application thereof in degrading bletilla striata polysaccharide, so as to solve or alleviate the technical problems of the parts.
In a first aspect, the embodiment of the application discloses a bacillus licheniformis which is named Bacillus licheniformis BJ2022, the preservation unit is China center for type culture collection, the address is in eight paths 299 of Wuchang district of Wuhan, hubei province, the preservation number is CCTCC NO: M2022816, and the preservation date is 2022, 6 and 7.
In a second aspect, an embodiment of the application discloses a microbial inoculum applied to degradation of bletilla striata polysaccharide, wherein the microbial inoculum comprises bacillus licheniformis according to the first aspect.
Further, the microbial inoculum contains the living microbial cells of the bacillus licheniformis or the microbial inoculum contains the mixed microbial cells of the living microbial cells and the dead microbial cells of the bacillus licheniformis.
Preferably, when the microbial inoculum contains a mixture of live and dead microbial cells of the bacillus licheniformis, the number of live microbial cells is higher than the number of dead microbial cells.
More preferably, the microbial inoculum comprises viable bacteria of the bacillus licheniformis.
Further, the microbial inoculum is a liquid microbial inoculum and/or a solid microbial inoculum.
Preferably, the preparation form of the microbial inoculum is bacterial liquid or freeze-dried bacterial cells.
In a third aspect, embodiments of the present application disclose the use of the bacillus licheniformis and/or the microbial inoculum of the first aspect for degrading mannans;
wherein the polysaccharide comprises beta-1, 4-glycosidic linkages.
Preferably, the application comprises degradation of bletilla polysaccharide.
In a fourth aspect, the embodiments of the present application disclose the use of the bacillus licheniformis and/or the microbial inoculum of the first aspect for the fermentative preparation of bletilla oligosaccharides.
In a fifth aspect, embodiments of the present application disclose a kit comprising bacillus licheniformis as described in the first aspect or the microbial inoculum as described in the second aspect.
In a sixth aspect, embodiments of the present application disclose a method for screening bacillus licheniformis according to the first aspect, comprising:
taking a fecal sample and preparing an intestinal flora dilution;
enrichment and screening of strains;
separating and purifying bacillus licheniformis strains;
and identification of the strain.
Further, the preparation method of the intestinal flora diluent is a gradient centrifugation method.
Further, the method for separating the bacillus licheniformis strain is the only carbon source screening method.
Further, the identification mode of the strain is morphological feature verification and 16S rDNA sequencing identification.
Compared with the prior art, the application has at least one of the following beneficial effects:
the application relates to bacillus licheniformis and application thereof in degradation of bletilla polysaccharide. When the bacillus licheniformis is used for degrading mannans, isomannans and mannooligosaccharides, beta-1, 4-D-mannoside bonds can be broken, oligosaccharide fragments are generated, and bletilla polysaccharide contains a large amount of beta-1, 4-D-mannoside bonds. Compared with the physical method and the chemical method, the bacillus licheniformis provided by the application is used for degrading the bletilla polysaccharide and the various mannans, isomannans and mannooligosaccharides containing beta-1, 4-D-mannoside bonds, has high efficiency, is green and environment-friendly, and is suitable for large-scale preparation of the bletilla oligosaccharide and other oligosaccharides.
Drawings
Fig. 1 shows the gram stain (1000×) and colony photograph of bacillus licheniformis Bacillus licheniformis BJ2022 provided by the examples of the present application.
FIG. 2 is a measurement of fermentation process parameters of bletilla oligosaccharides provided in the examples of the awake application; wherein A is a bacillus licheniformis growth curve, B is a fermentation broth pH value change curve, C is a fermentation broth total sugar content change curve, and D is a fermentation broth reducing sugar content change curve.
FIG. 3 is a diagram of structural identification of bletilla striata oligosaccharides according to the examples of the present application; wherein A is the molecular weight of the bletilla oligosaccharide monosaccharide detected by HPGPC, and B, C is the composition of the two bletilla oligosaccharide monosaccharides detected by HPLC.
Detailed Description
In order to make the objects, technical solutions and advantages of the present application more apparent, the present application will be further described in detail with reference to examples. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the present application. Reagents not specifically and individually described in this application are all conventional reagents and are commercially available; methods which are not specifically described in detail are all routine experimental methods and are known from the prior art.
It should be noted that, the terms "first," "second," and the like in the description and the claims of the present invention and the above drawings are used for distinguishing similar objects, and are not necessarily used for describing a particular sequence or order, nor do they substantially limit the technical features that follow. It is to be understood that the data so used may be interchanged where appropriate such that the embodiments of the invention described herein may be implemented in sequences other than those illustrated or otherwise described herein. Furthermore, the terms "comprises," "comprising," and "having," and any variations thereof, are intended to cover a non-exclusive inclusion, such that a process, method, system, article, or apparatus that comprises a list of steps or elements is not necessarily limited to those steps or elements expressly listed but may include other steps or elements not expressly listed or inherent to such process, method, article, or apparatus.
In a first aspect, the embodiment of the application discloses a bacillus licheniformis, which is named Bacillus licheniformis BJ2022, and has a preservation number of CCTCC NO: M2022816 as a preservation unit of China center for type culture Collection.
The embodiment of the application discloses a screening method of bacillus licheniformis, which comprises the following specific steps:
1. preparation of intestinal flora bacterial liquid
The fecal sample collection site of the present example was martial arts, specifically 5 healthy volunteers (male: female=3:2). After taking 2g of feces from each volunteer, thoroughly shaking and mixing them with 20mL of anaerobic PBS (containing 0.5g/L of L-cysteine), centrifuging at 1000rpm for 5min, and removing food residues. The fecal suspension was centrifuged at 6000rpm for 5min and resuspended in 20mL of anaerobic PBS to obtain a 10% intestinal flora broth.
1. Culture and isolation of strains
Further diluting the intestinal flora bacterial solution into 10 according to a 10-fold dilution method -1 、10 -2 、10 -3 、10 -4 、10 -5 、10 -6 A dilution of the sample suspension;
selecting dilution of 10 -4 、10 -5 、10 -6 The diluted sample suspensions were pipetted with 1mL sterile respectively onto plates of bletilla polysaccharide carbon source Selection Medium (SM) which were incubated in an incubator at 37 ℃ for 24 hours to obtain colonies.
2. Separation and purification of bacillus licheniformis
Screening a flat colony with irregular edges, white color and rough surface wrinkles in the middle of about 3-4 mm on an SM flat plate;
culturing the screened bacterial colony by a nutrient broth culture medium (LB), and taking fresh bacterial liquid to obtain longbacillus which is 100 times-4.0 mu m, 0.8-1.0 mu m in width and blue-violet or purple in gram staining by an optical microscope;
and (5) scribing and purifying the screened bacterial colony on an LB plate, and then preserving the bacterial colony on a test tube inclined plane for standby.
3. Identification of Bacillus licheniformis Strain
The application extracts DNA from the strain screened by the application, and carries out 16SrDNA detection, and the detection result shows that the strain can be identified as bacillus licheniformis, is named Bacillus licheniformis BJ2022 and is preserved in China Center for Type Culture Collection (CCTCC) with the preservation number of M2022816 in 6 months of 2022.
In a second aspect, embodiments of the present application provide a microbial inoculant comprising bacillus licheniformis (Bacillus licheniformis BJ 2022) as described above for use in degrading bletilla striata polysaccharides or mannans, isomannides and mannooligosaccharides comprising beta-1, 4-D-mannoside linkages.
In the present application, the concentration of Bacillus licheniformis in the microbial inoculum is not particularly limited, and may be specifically selected according to specific conditions.
In the present application, the microbial inoculum contains living and/or dead bacteria of the bacillus licheniformis. Preferably, the microbial inoculum contains a mixture of live and dead bacteria of the bacillus licheniformis (Bacillus licheniformis BJ 2022). More preferably, the microbial inoculum contains viable bacteria of the bacillus licheniformis (Bacillus licheniformis BJ 2022). When the microbial inoculum contains a mixture of live and dead microbial cells of the Bacillus licheniformis (Bacillus licheniformis BJ 2022), the number of live microbial cells is preferably higher than the number of dead microbial cells.
In the present application, the dosage form of the microbial inoculum is not particularly limited, and may be prepared into various dosage forms, such as liquid microbial inoculum and/or solid microbial inoculum, and corresponding excipients and the like may be added according to the intended use. Preferably, the preparation form of the microbial inoculum is bacterial liquid or freeze-dried bacterial cells. The addition of excipients to the bacterial agents in which the dosage forms are known to those skilled in the art is not described in detail herein.
In a third aspect, embodiments of the present application disclose the use of the bacillus licheniformis and/or the microbial inoculum of the first aspect in degrading polysaccharides;
wherein the polysaccharide comprises beta-1, 4-glycosidic linkages.
Preferably, the application comprises degradation of bletilla polysaccharide.
According to the application, the application of the bacillus licheniformis or the microbial inoculum to degrading polysaccharide is respectively verified, wherein the polysaccharide comprises bletilla polysaccharide, locust bean gum, guar gum, astragalus polysaccharide, rhizoma polygonati polysaccharide, xanthan gum, grifola frondosa polysaccharide, cellulose, konjac gum and pachyman.
Preparing polysaccharide solution of 2.5mg/mL, weighing 50mg polysaccharide (rhizoma bletilla polysaccharide, locust bean gum, guar gum, radix astragali polysaccharide, rhizoma Polygonati polysaccharide, xanthan gum, maitake Mushroom polysaccharide, cellulose, konjac gum, pachyman), and fixing volume to 20mL.
According to the application, the number of thalli in the bacillus licheniformis and/or the microbial inoculum is at least 10 7 CFU (number of cells degrading 50mg polysaccharide, if the mass of polysaccharide is changed, the number of cells is changed), preferably, the number of viable cells in the Bacillus licheniformis and/or the microbial inoculum is at least 10 7 CFU. In the present application, the number of cells can be measured according to GB 4789.2-94.
According to the present application, the degradation conditions include: the temperature was 35℃and the pH was 8 for 2h.
Experimental results: the results of degradation of different polysaccharides by bacillus licheniformis and/or the microbial agents are shown in table 1:
TABLE 1
As can be seen from Table 1, the Bacillus licheniformis and/or the microbial inoculum described herein have high activity on rhizoma bletillae polysaccharide and konjac gum, wherein the degradation rate of the rhizoma bletillae polysaccharide is slightly higher than that of the konjac gum.
Analysis: the bletilla polysaccharide is a high molecular viscous polysaccharide, the chemical components of the bletilla polysaccharide are glucomannan (including beta-glucose and beta-mannose), and monosaccharide residues are connected by beta-1, 4-glycosidic bonds; the konjac glucomannan is a polysaccharide formed by connecting D-mannose and D-glucose, and the ratio of the D-mannose to the D-glucose is 1:1.6, monosaccharides are also linked by β -1, 4-glycosidic linkages; the bacillus licheniformis and/or the microbial inoculum can effectively break beta-1, 4 glycosidic bonds, and the action substrates are mannans, glucomannans, galactomannans and the like, so that the bacillus licheniformis and/or the microbial inoculum has high degradation rate on bletilla polysaccharide and konjac glucomannan. Similarly, we can conclude that the Bacillus licheniformis and/or the microbial inoculum described herein have higher degradation rates for polysaccharides containing beta-1, 4 glycosidic linkages.
In a fourth aspect, the embodiments of the present application disclose the use of the bacillus licheniformis and/or the microbial inoculum of the first aspect for the fermentative preparation of bletilla oligosaccharides.
In the embodiment of the application, a method for preparing bletilla striata oligosaccharides by using bacillus licheniformis fermentation is provided, and the specific implementation steps are as follows:
(1) 30g of bletilla striata was taken and added to 1L of buffer (pH 7.5) (the solution comprised 0.2g (NH) 4 ) 2 SO 4 ，0.2g KH 2 PO 4 ，0.4g NaCl，0.04gmgSO 4 ) Soaking for 12h at low temperature. Pulping by using a wall breaking machine.
(2) Transferring the mixed solution obtained in the step (1) into a 5L fermentation tank, and sterilizing for 15min at 115 ℃.
(3) And (3) placing the sterilized fermentation tank in the step (2) on a full-automatic fermentation system, and inoculating the activated bacillus licheniformis bacteria liquid into the fermentation tank according to the proportion of 5%. The fermentation parameters were set as: 10% of dissolved oxygen, 100rpm of rotating speed and 37 ℃ of temperature, and ventilation fermentation for 72h. The change of OD600, pH, total sugar and reducing sugar of the culture medium was monitored periodically during the fermentation, and the results are shown in FIG. 2.
(4) And (3) taking out the fermentation liquor in the step (3), centrifuging at 8000rpm for 5min, concentrating the supernatant to a feed-liquid ratio of 1:5, adding absolute ethyl alcohol to an alcohol concentration of 80%, standing at 4 ℃ for 12h, and collecting the precipitate.
(5) And (3) re-dissolving the precipitate with distilled water, concentrating on a rotary evaporator, collecting all sugar solutions, and freeze-drying to obtain bletilla striata oligosaccharide powder.
Results: as shown in FIG. 3, the average molecular weight of the bletilla striata oligosaccharide is 3000Da, and the monosaccharide composition is glucose and mannose.
In a fifth aspect, embodiments of the present application disclose a kit comprising bacillus licheniformis and/or a microbial inoculum as described above.
From the above results, it is known that when the bacillus licheniformis provided by the application is applied to degradation of mannans, isomannans and mannooligosaccharides, beta-1, 4-D-mannosides can be broken to generate oligosaccharide fragments, and bletilla polysaccharide contains a large amount of beta-1, 4-D-mannosides. Compared with the physical method and the chemical method, the bacillus licheniformis provided by the application is used for degrading the bletilla polysaccharide and the various mannans, isomannans and mannooligosaccharides containing beta-1, 4-D-mannoside bonds, has high efficiency, is green and environment-friendly, and is suitable for large-scale preparation of the bletilla oligosaccharide and other oligosaccharides.
The foregoing is merely a preferred embodiment of the present application, but the scope of the present application is not limited thereto, and any changes or substitutions easily contemplated by those skilled in the art within the technical scope of the present application should be covered by the scope of the present application.
Claims (8)
1. Bacillus licheniformis, which is namedBacillus licheniformisBJ2022 is preserved in China center for type culture collection, and has an address of 299 th No. eight channels in Wuchang district of Wuhan, hubei province, a preservation number of CCTCC NO: M2022816, and a preservation date of 2022, 6 months and 7 days.
2. A microbial inoculant comprising the bacillus licheniformis of claim 1.
3. The microbial inoculum of claim 2, wherein the microbial inoculum comprises a mixture of live and dead microbial cells of the bacillus licheniformis.
4. The microbial agent according to claim 3, wherein the number of living microbial cells is higher than the number of dead microbial cells.
5. The microbial inoculum of any one of claims 2-4, wherein the microbial inoculum is a liquid microbial inoculum or a solid microbial inoculum.
6. Use of the bacillus licheniformis of claim 1 and/or the microbial inoculum of any one of claims 2-5 for degrading bletilla striata polysaccharides.
7. The use of the bacillus licheniformis of claim 1 and/or the microbial inoculum of any one of claims 2-5 in the fermentation preparation of bletilla striata oligosaccharides.
8. A kit comprising bacillus licheniformis of claim 1 or the microbial inoculum of any of claims 2-5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210938151.6A CN115232773B (en) | 2022-08-05 | 2022-08-05 | Bacillus licheniformis and application thereof in degradation of bletilla striata polysaccharide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210938151.6A CN115232773B (en) | 2022-08-05 | 2022-08-05 | Bacillus licheniformis and application thereof in degradation of bletilla striata polysaccharide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115232773A CN115232773A (en) | 2022-10-25 |
| CN115232773B true CN115232773B (en) | 2023-12-19 |
Family
ID=83679108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210938151.6A Active CN115232773B (en) | 2022-08-05 | 2022-08-05 | Bacillus licheniformis and application thereof in degradation of bletilla striata polysaccharide |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115232773B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101386824A (en) * | 2008-07-30 | 2009-03-18 | 黑龙江大学 | Engineering strain for producing mannanase |
| CN102071156A (en) * | 2009-12-22 | 2011-05-25 | 黑龙江大学 | Bacillus licheniformis capable of producing beta-mannanase |
| KR20110076337A (en) * | 2009-12-29 | 2011-07-06 | 경남과학기술대학교 산학협력단 | Cellulase-producing bacillus licheniformis cs48 and its culture fluid |
-
2022
- 2022-08-05 CN CN202210938151.6A patent/CN115232773B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101386824A (en) * | 2008-07-30 | 2009-03-18 | 黑龙江大学 | Engineering strain for producing mannanase |
| CN102071156A (en) * | 2009-12-22 | 2011-05-25 | 黑龙江大学 | Bacillus licheniformis capable of producing beta-mannanase |
| KR20110076337A (en) * | 2009-12-29 | 2011-07-06 | 경남과학기술대학교 산학협력단 | Cellulase-producing bacillus licheniformis cs48 and its culture fluid |
Non-Patent Citations (2)
| Title |
|---|
| 地衣芽孢杆菌产β-甘露聚糖酶分批发酵动力学模型的建立;田雪;解鑫;周晓杭;葛菁萍;凌宏志;宋刚;平文祥;;中国农学通报(第18期);全文 * |
| 枯草芽孢杆菌群β-甘露聚糖酶基因克隆及同源性分析;刘勇;毛爱军;李辉;程池;;基因组学与应用生物学(第05期);全文 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115232773A (en) | 2022-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101381694B (en) | Bacteria cellulose producing bacteria and method for preparing bacteria cellulose using above bacterial strain | |
| CN108220169B (en) | Separation screening and identification method of strain for degrading polystyrene | |
| CN107118990A (en) | Its production γ PGA of high yield γ PGA bacterial strains and application method | |
| CN106754571B (en) | A kind of complex microorganism deodorant and preparation method thereof | |
| CN108929859A (en) | One type bacterial strain of bacillus HB172198 and its application | |
| CN104893997B (en) | A kind of bacterial strain and its fermentation process of temperature production chitinase | |
| CN111100825B (en) | Bacillus and application thereof in industry | |
| CN106434475B (en) | One streptomycete category polysaccharide degradation bacteria and its cultural method and application | |
| CN1769425A (en) | Bifidobacteria exocellular polysaccharide and its production method and special purpose production strain | |
| CN108546660A (en) | Chitin deacetylase superior strain and its application | |
| CN108294224A (en) | A method of it is fermented using lactobacillus plantarum and removes heavy metal cadmium in rice | |
| CN108823116B (en) | Rhodococcus equi mutant strain for producing chitin deacetylase and application thereof | |
| CN105505816A (en) | Sphingomonas paucimobilis strain and application thereof | |
| CN115232773B (en) | Bacillus licheniformis and application thereof in degradation of bletilla striata polysaccharide | |
| CN102690773B (en) | Enterobacteria strain FY-07 and method thereof for producing bacterial cellulose by static liquid submerged fermentation | |
| CN115418337B (en) | Lignin degrading bacterium and application thereof in rice straw micro-storage | |
| CN101503722A (en) | Biological polysaccharide, and production and use thereof | |
| CN108913629B (en) | Bacterium for producing cellulase, preparation method and application thereof | |
| CN1900277A (en) | Alpha-galactosidase solid fermenting producing method | |
| CN112458022B (en) | Bacillus licheniformis Bl22 for high yield of chitin deacetylase and related products and application thereof | |
| CN1834222A (en) | Fetid aspergillic strain and uses | |
| CN109355238B (en) | A kind of enterobacter cloacae strain and its application in degradation brown alga | |
| CN108004145B (en) | Black fungus wall breaking method | |
| CN117229979B (en) | Extended microbubble strain for producing algin lyase and application thereof | |
| CN115554206B (en) | Composite ferment for enhancing cell viability and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20231115 Address after: No. 128-2, Bowu Avenue, Xinchong Street, Xinzhou District, Wuhan City, Hubei Province, 430000 Applicant after: Wuhan Sishengyuan Biotechnology Co.,Ltd. Address before: 430000, No.16, Huangjiahu West Road, Hongshan District, Wuhan City, Hubei Province Applicant before: Liu Hongtao |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |